On November 20, the National Biochemical Testing Standardization Technical Committee Biological Method Working Group Founding Conference and the first working meeting were held in Shenzhen Convention and Exhibition Center. The person in charge of the National Biochemical Testing Standardization Technical Committee announced that Shenzhen Huayinkang Gene Technology Co., Ltd. will be awarded as the leader unit, and pointed out that the SAC / TC387 / WG3 working group will play an important role in promoting the standardization of China ’s biochemical testing standard system. The continuous development and re-innovation of the industry-university-research model in the pharmaceutical industry has opened up a new way of thinking.
Shenzhen Huayinkang Gene Technology Co., Ltd. was established in January 2008. It is a professional R & D, production and sales of ultra-high-throughput gene sequencing equipment and supporting biological reagents, genetic analysis software, biological information data technology services, biomedical treatment as the main body High-tech enterprise. The company currently has more than 30 independent innovation patents, as well as a returnee elite and domestic authority at the top level in the field of molecular research and diagnosis, led by Dr. Sheng Sitong, who was selected as the first batch of countries to introduce overseas high-level talents in the "Thousand Talents Program". Professional management and technical development team.
The Huayinkang series high-throughput sequencing system includes a full set of biological reagents and information system analysis software. It has independent intellectual property rights and has achieved a "zero" breakthrough in domestic high-throughput gene sequencing equipment and technology. Its performance indicators have reached the same level. The international leading level of products. The system can be widely used in related genome function resequencing and large-scale expression profiling, cancer cell expression profiling and clinical tumor lesion detection, clinical infectious disease virus detection and clinical biopsy identification, fetal genetic defect diagnosis and genetic gene research, new drug research And drug response measurement, animal and plant gene measurement research, bioenergy research and other fields, more importantly, the clinical application of this technology makes modern medicine to the goal of personalized medicine based on different gene profiles and different treatments. , Has taken a crucial step to make it possible to implement "customized medical treatment" to provide disease prevention and treatment measures suitable for each human body.
Huayinkang's personalized biotherapy technology combining genetic testing and biotherapy is the first new and unique technology in China. It is the fourth type of cancer diagnosis and treatment method developed after surgery, radiotherapy and chemotherapy. Fully recognized by the international medical community. The winner of the 2011 Nobel Prize in Medical Physiology is the scientist who has made outstanding achievements in this field. Gene testing combined with biological therapy for cancer treatment will be a milestone revolution in the field of oncology medicine, and will bring the diagnostic pathology discipline into a new era of molecular pathology and personalized treatment.
In less than 4 years since its establishment, Huayinkang has always maintained an active industry-university-research cooperation relationship with famous universities and scientific research institutions, and signed technical cooperation with Shanghai Jiaotong University, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, and Sun Yat-sen University, etc. Agreement to maintain strategic leadership. In June 2011, with the approval of the National Biochemical Testing Standardization Technical Committee, the standard setting working group SAC / TC387 / WG3 (WG3 working group for short) was established. The working group was convened by Shenzhen Huayinkang Gene Technology Co., Ltd. The first unit in Shenzhen biomedical field to establish a national standard working group.
More than 100 representatives from enterprises and institutions such as China National Institute of Testing Technology, Shenzhen Institute of Standards and Technology, Shenzhen Huada Gene Research Institute, Peking University Shenzhen Hospital, Shenzhen Medical Device Industry Association participated in the National Biochemical Testing Standardization Technical Committee Biological Method The working group founding meeting and the first working meeting. The working group also hired academician Chen Runsheng of the Beijing Institute of Biophysics, Chinese Academy of Sciences, academician Zhao Guoping of the National Human Genome South Research Center, and Tan Heping, president of the China Institute of Test Technology, as authoritative experts in the field of biology in China. Participants agreed that the establishment of the working group will effectively promote the participation of Chinese biological enterprises in international and domestic standardization activities and gradually establish a synchronization mechanism between research and development and standardization, and formulate biological standards with independent intellectual property rights for our country and enhance China's standardization in the world biological field. The right to speak in the field provides strong support.
Rechargeable Nose Hair Trimmer
Rechargeable Nose Hair Trimmer,Nose Hair Trimmers For Men,Custom Nose Hair Trimmer,Adult Nose Hair Trimmer
ZHEJIANG SHENGFA ELECTRIC APPLIAMNCES CO.,LTD , https://www.sfelectricappliances.com